کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8434479 | 1546644 | 2018 | 64 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
AAVMSLNColony stimulating factor 1 receptorCSF1RIL-12TLR-3PARPLPSIFN-γEpigallocatechin-3-gallateBMMCTGFLUCTAAFITCEGCGTMEtumor-associated antigen - آنتی ژن مرتبط با تومورAnti-tumor effect - اثر ضد تومورimmunotherapy - ایمونوتراپیinterferon-gamma - اینترفرون گاماinterleukin-12 - اینترلوکین -12Dendritic cell - سلول دندریتیکConnective tissue growth factor - فاکتور رشد بافت همبندphycoerythrin - فایکوئیریدینfluorescein isothiocyanate - فلوئورسین ایسوتیوسیاناتluciferase - لوسیفرازlipopolysaccharide - لیپوپلی ساکاریدMesothelin - مزوتلینTumor microenvironment - میکرو محیط زیست تومورAdeno-associated virus - ویروس Adeno مرتبط استpoly(I:C) - پلی (I: C)poly ADP ribose polymerase - پلی ADA ریبوز پلی مرازPolyinosinic:polycytidylic acid - پلی سونیک: پلیسییدیدیل اسیدToll-like receptor 3 - گیرنده پولی 3
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
تحقیقات سرطان
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation](/preview/png/8434479.png)
چکیده انگلیسی
As a tumor antigen, mesothelin (MSLN) can be identified in various malignancies. MSLN is potential for antigen-specific cancer vaccines. We generated a novel chimeric DNA vaccine using antigen-specific connective tissue growth factor lined with MSLN (CTGF/MSLN). The anti-tumor effects of the CTGF/MSLN DNA vaccine combined with anti-CD40 Ab and toll-like receptor 3 ligand-poly(I:C) were validated in an MSLN-expressing model. CTGF/MSLN DNA with anti-CD40Ab and poly(I:C) vaccinated mice demonstrated potent anti-tumor effects with longer survival and less tumor volumes. An increase in MSLN-specific CD8+ T cells and anti-MSLN Ab titers was also noted in CTGF/MSLN DNA with anti-CD40Ab and poly(I:C) vaccinated mice. The CTGF/MSLN DNA vaccine combined with immuno-modulator EGCG also generated potent anti-tumor effects. Immuno-modulators could enhance the antigen-specific anti-tumor effects of CTGF/MSLN DNA vaccine through promoting the DC maturation. In addition, MSLN-specific cell-based vaccine with AAV-IL-12 and the CTGF/MSLN DNA vaccine with anti-CD40Ab/polyp(I:C) generated more potent anti-tumor effects than the other combinational regimens. The results indicate that an MSLN-specific DNA vaccine combined with immuno-modulators may be an effective immunotherapeutic strategy to control MSLN-expressing tumors including ovarian and pancreastic cancers, and malignant mesothelioma.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Cancer Letters - Volume 425, 1 July 2018, Pages 152-163
Journal: Cancer Letters - Volume 425, 1 July 2018, Pages 152-163
نویسندگان
Yu-Li Chen, Ming-Cheng Chang, Ying-Cheng Chiang, Han-Wei Lin, Nai-Yun Sun, Chi-An Chen, Wei-Zen Sun, Wen-Fang Cheng,